Results
1
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
1 companies
Oryzon Genomics
Market Cap: €216.3m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders.
ORY
€2.79
7D
4.1%
1Y
3.3%